Literature DB >> 8769288

Hyponatremia with consciousness disturbance caused by omeprazole administration. A case report and literature review.

S Shiba1, K Sugiura, A Ebata, T Kagaya, G Tomori, F Marumo, C Sato.   

Abstract

A 68-year-old man developed severe consciousness disturbance after daily administration of 20 mg omeprazole for four days for the treatment of bleeding gastric ulcer. Systemic investigation revealed severe hyponatremia (111 meq/liter). Consciousness did not become clear until his sodium intake was increased to 480 meq/day, and his serum sodium concentrations reached 130 meq/liter. After the discontinuation of omeprazole, his serum sodium levels returned to the normal range with only minimum supplementation of sodium in the form of dietary sodium chloride intake of 10 g/day. Although the mechanism of hyponatremia induced by omeprazole is not clear, an excessive loss of urinary sodium appears to be more likely than water retention with an increase in fluid intake. The literature was also reviewed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8769288     DOI: 10.1007/bf02087909

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  5 in total

1.  [Severe hyponatremia: possible role of omeprazole].

Authors:  E Kaloustian; P Veyssier
Journal:  Presse Med       Date:  1992-05-23       Impact factor: 1.228

2.  [Severe hyponatremia induced by meprazole].

Authors:  R Gonthier; K Bouchou; C Guy; P Cathebras; H Rousset
Journal:  Presse Med       Date:  1993-02-06       Impact factor: 1.228

3.  Hyponatremia caused by omeprazole treatment.

Authors:  R Y Durst; R Pipek; Y Levy
Journal:  Am J Med       Date:  1994-10       Impact factor: 4.965

4.  Electrolyte disturbance with omeprazole therapy.

Authors:  C Melville; A Shah; D Matthew; P Milla
Journal:  Eur J Pediatr       Date:  1994-01       Impact factor: 3.183

5.  [Evaluation of unexpected and toxic effects of omeprazole (Mopral) reported to the regional centers of pharmacovigilance during the first 22 postmarketing months].

Authors:  A Castot; I Bidault; R Dahan; M L Efthymiou
Journal:  Therapie       Date:  1993 Sep-Oct       Impact factor: 2.070

  5 in total
  8 in total

1.  Hyponatraemic encephalopathy: an unusual stroke mimic.

Authors:  William Wareing; Bhagyashree Dhotore; Karim Mahawish
Journal:  BMJ Case Rep       Date:  2015-01-23

Review 2.  Drug-induced syndrome of inappropriate antidiuretic hormone secretion. Causes, diagnosis and management.

Authors:  T Y Chan
Journal:  Drugs Aging       Date:  1997-07       Impact factor: 3.923

3.  Hyponatraemia in very old nonhospitalised people: association with drug use.

Authors:  Jens-Ulrik Rosholm; Hanne Nybo; Karen Andersen Ranberg; Bodil Himmelstrup; Erik Skjelbo; Kaare Christensen; Lars F Gram
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

4.  Association of proton pump inhibitor use and significant hyponatremia-a US population-based case-control study.

Authors:  Emran El-Alali; Emad Al Jaber
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-04-22

5.  Severe Electrolyte Disturbances Due to Proton Pump Inhibitor Therapy: An Underrecognized Problem with Potentially Severe Sequelae.

Authors:  Senyo Tagboto
Journal:  Am J Case Rep       Date:  2022-07-15

6.  Pantoprazole-related Symptomatic Hyponatremia.

Authors:  Filipa Ferreira; Sofia Mateus; Ana Rita Santos; Hugo Moreira; Nuno Ribeiro Ferreira
Journal:  Eur J Case Rep Intern Med       Date:  2016-01-05

7.  Omeprazole-induced and pantoprazole-induced asymptomatic hyponatremia: a case report.

Authors:  Isabel J B van der Zalm; Tom J M Tobé; Susan J J Logtenberg
Journal:  J Med Case Rep       Date:  2020-06-29

8.  A Prospective, Placebo-Controlled Pilot Evaluation of the Effect of Omeprazole on Serum Calcium, Magnesium, Cobalamin, Gastrin Concentrations, and Bone in Cats.

Authors:  E Gould; C Clements; A Reed; L Giori; J M Steiner; J A Lidbury; J S Suchodolski; M Brand; T Moyers; L Emery; M K Tolbert
Journal:  J Vet Intern Med       Date:  2016-04-08       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.